|
US4036840A
(en)
*
|
1972-06-07 |
1977-07-19 |
Icn Pharmaceuticals |
2-Substituted-s-triazolo[1,5a]pyrimidines
|
|
WO1993000313A2
(en)
|
1991-06-27 |
1993-01-07 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
|
UA59433C2
(uk)
|
1998-01-27 |
2003-09-15 |
Авентіс Фармасьютікалс Продактс Інк. |
ЗАМІЩЕНІ ОКСОАЗАГЕТЕРОЦИКЛІЧНІ ІНГІБІТОРИ ФАКТОРА Хa ТА ПРОМІЖНІ СПОЛУКИ ДЛЯ ЇХ ОТРИМАННЯ
|
|
US6194410B1
(en)
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
US20040014744A1
(en)
|
2002-04-05 |
2004-01-22 |
Fortuna Haviv |
Substituted pyridines having antiangiogenic activity
|
|
KR20050047132A
(ko)
|
2002-10-03 |
2005-05-19 |
버텍스 파마슈티칼스 인코포레이티드 |
신경계 질환 치료용 피페라진 및 피페리딘 유도체
|
|
EP1644003A1
(en)
|
2003-06-04 |
2006-04-12 |
Vernalis (Cambridge) Limited |
Triazolo ´1,5-a!pyrimidines and their use in medicine
|
|
EA011300B1
(ru)
|
2003-07-16 |
2009-02-27 |
Янссен Фармацевтика Н.В. |
Производные триазолопиримидина в качестве ингибиторов киназы гликогенсинтазы-3
|
|
WO2005063738A1
(ja)
|
2003-12-29 |
2005-07-14 |
Banyu Pharmaceutical Co.,Ltd |
新規２－へテロアリール置換ベンズイミダゾール誘導体
|
|
JP4958786B2
(ja)
|
2004-09-20 |
2012-06-20 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
複素環誘導体および治療薬としてのそれらの使用
|
|
JP5149009B2
(ja)
|
2004-09-20 |
2013-02-20 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリダジン誘導体
|
|
US7713973B2
(en)
|
2004-10-15 |
2010-05-11 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
CA2592457A1
(en)
*
|
2005-01-14 |
2006-07-20 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
US7507842B2
(en)
|
2005-08-12 |
2009-03-24 |
Radiorx, Inc. |
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
WO2007113136A1
(de)
|
2006-03-30 |
2007-10-11 |
Basf Aktiengesellschaft |
Verwendung von substituierten riazolopyrimidinen zur bekämpfung von phyto pathogenen schadpilzen
|
|
JP2007332061A
(ja)
|
2006-06-14 |
2007-12-27 |
Nippon Kayaku Co Ltd |
新規ピラゾロ［１，５−ａ］ピリミジン誘導体及びその用途
|
|
US8153803B2
(en)
|
2006-07-18 |
2012-04-10 |
The General Hospital Corporation |
Compositions and methods for modulating sirtuin activity
|
|
US7928103B2
(en)
|
2006-10-17 |
2011-04-19 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the CB2 receptor
|
|
CA2693159C
(en)
*
|
2007-07-18 |
2016-05-24 |
Shawn T. Branum |
Sulfonamides as trpm8 modulators
|
|
US8138168B1
(en)
|
2007-09-26 |
2012-03-20 |
Takeda Pharmaceutical Company Limited |
Renin inhibitors
|
|
GB0719803D0
(en)
|
2007-10-10 |
2007-11-21 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
CN101560212B
(zh)
*
|
2009-05-26 |
2011-03-16 |
华中师范大学 |
1,2,4-三唑并[1,5-a]嘧啶-2-乙基硫醚双取代衍生物的制备及其应用
|
|
JP5937102B2
(ja)
|
2010-12-14 |
2016-06-22 |
エレクトロフォレティクス リミテッド |
カゼインキナーゼ１デルタ（ｃｋ１デルタ）阻害剤
|
|
WO2012114222A1
(en)
|
2011-02-23 |
2012-08-30 |
Pfizer Inc. |
IMIDAZO[5,1-f][1,2,4]TRIAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
|
|
ES2575092T3
(es)
|
2011-06-27 |
2016-06-24 |
Janssen Pharmaceutica, N.V. |
Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxalina
|
|
CA2849726A1
(en)
|
2011-09-23 |
2013-03-28 |
Advinus Therapeutics Limited |
Amide compounds, compositions and applications thereof
|
|
CN103183675A
(zh)
*
|
2011-12-27 |
2013-07-03 |
山东轩竹医药科技有限公司 |
磷酸二酯酶-4抑制剂
|
|
US9034882B2
(en)
|
2012-03-05 |
2015-05-19 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
IN2014DN07384A
(OSRAM)
|
2012-03-09 |
2015-04-24 |
Lexicon Pharmaceuticals Inc |
|
|
US9193736B2
(en)
*
|
2013-06-11 |
2015-11-24 |
Janssen Pharmaceutica, Nv |
PDE 10a inhibitors for the treatment of type II diabetes
|
|
US9328095B2
(en)
*
|
2013-10-15 |
2016-05-03 |
Janssen Pharmaceutica Nv |
Heteroaryl linked quinolinyl modulators of RORgammat
|
|
AU2015223049B2
(en)
|
2014-02-27 |
2019-03-21 |
Merck Patent Gmbh |
Heterocyclic compounds as NaV channel inhibitors and uses thereof
|
|
WO2015140051A1
(en)
|
2014-03-19 |
2015-09-24 |
Boehringer Ingelheim International Gmbh |
Heteroaryl sik inhibitors
|
|
HRP20212035T1
(hr)
|
2014-04-23 |
2022-04-01 |
Dart Neuroscience Llc |
Pripravci koji sadrže supstituirane [1,2,4]triazolo[1,5-a]pirimidin-7-il spojeve kao inhibitore pde2
|
|
CN105566321B
(zh)
|
2014-10-29 |
2020-04-21 |
广东东阳光药业有限公司 |
杂芳化合物及其在药物中的应用
|
|
WO2016107602A1
(zh)
|
2015-01-01 |
2016-07-07 |
成都贝斯凯瑞生物科技有限公司 |
一类取代氮杂环衍生物及其应用
|
|
WO2016145614A1
(en)
|
2015-03-17 |
2016-09-22 |
Merck Sharp & Dohme Corp. |
Triazolyl pyrimidinone compounds as pde2 inhibitors
|
|
WO2017000276A1
(en)
|
2015-07-01 |
2017-01-05 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocyclic compounds as pde2 inhibitors
|
|
WO2017000277A1
(en)
|
2015-07-01 |
2017-01-05 |
Merck Sharp & Dohme Corp. |
Substituted triazolo bicycliccompounds as pde2 inhibitors
|
|
WO2017066705A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
|
MX2018005342A
(es)
|
2015-11-02 |
2018-08-15 |
Janseen Pharmaceutica Nv |
Compuesto de [1,2,4]triazolo[1,5-a]pirimidin-7-ilo.
|
|
WO2017157882A1
(en)
|
2016-03-14 |
2017-09-21 |
Université Catholique de Louvain |
Serine biosynthetic pathway inhibitors
|
|
ES2912264T3
(es)
|
2016-11-02 |
2022-05-25 |
Janssen Pharmaceutica Nv |
Compuestos de [1,2,4]triazolo[1,5-a]pirimidina como inhibidores de PDE2
|
|
BR112019008163A2
(pt)
|
2016-11-02 |
2019-07-09 |
Janssen Pharmaceutica Nv |
compostos de [1,2,4]triazolo[1,5-a]pirimidina como inibidores de pde2
|
|
SG11201903892UA
(en)
|
2016-11-02 |
2019-05-30 |
Janssen Pharmaceutica Nv |
[1,2,4]triazolo[1,5-a]pyrimidine derivatives as pde2 inhibitors
|
|
CA3044762A1
(en)
|
2016-12-16 |
2018-06-21 |
Janssen Pharmaceutica Nv |
Bicyclic oga inhibitor compounds
|